Atrial fibrillation is the most common sustained cardiac arrhythmia. The disorder has been known for over a hundred years, and is regarded by many as an acceptable alternative to sinus rhythm. This is unlikely to be correct; atrial fibrillation leads to thromboembolism, poor quality of life, and impaired left ventricular function. The false perception arises because the symptomatic impact of atrial fibrillation can be subtle and non-specific, and the deleterious effects occur insidiously or as events remote from the time of onset of the arrhythmia. In these regards, atrial fibrillation is better compared to disorders such as hypertension rather than ventricular tachycardia or acute coronary syndromes. As four-fifths of patients with permanent atrial fibrillation and half of those with the paroxysmal form have other cardiovascular disease, it is difficult to determine which symptoms are due to atrial fibrillation and which stem from the underlying disease.
The importance of atrial fibrillation as a cause of stroke and other thromboembolic complications is well docu- Inadequate heart rate control is the prime suspect, and certainly some have documented reversal of cardiomyopathy without restoration of sinus rhythm through rigorous rate control by AV nodal ablation,'0 or even using drugs which, although negatively dromotropic, are also negatively inotropic." Tachycardia cardiomyopathy can also result from regular tachycardias or near incessant paroxysmal tachycardias. It is odd, however, that atrial flutter has very rarely been reported as the culprit arrhythmia, as it often causes a tachycardia of 150 beats/min. This is faster than the resting rate typically seen in atrial fibrillation, and the irregularity of the cardiac rhythm in atrial fibrillation is a possible co-factor to explain this discrepancy. At the same mean heart rate, an irregular rhythm is associated with a lower cardiac output than a regular one,'5 16 and atrial fibrillation causes relative hypoperfusion of the endocardium as well as increased myocardial oxygen extraction.'7 A possible mechanism for this can be found in the phenomenon of post-extrasystolic potentiation, whereby the beat following a short duration cycle generates more work than the average but is associated with an even higher rise in oxygen consumption and a consequent drop in cardiac efficiency.'8 Many patients with atrial fibrillation have cardiac failure; often no clear independent cause for the failure is documented. In such patients atrial fibrillation should be considered as a potential cause of the heart failure rather than merely a consequence. Attempts at cardioversion or rigorous heart rate control should be undertaken despite the associated presence of heart failure.
It is possible that the long term deleterious effects of atrial fibrillation on left ventricular function may be far more widespread than is currently appreciated. In a prospective study, Van Gelder et al'9 found that among patients who remained in sinus rhythm for at least six months following cardioversion, a progressive improvement in left ventricular function and exercise capacity appeared to occur. Recovery of left atrial mechanical function, which is known to be impaired for hours to several weeks following cardioversion20 did not wholly explain these findings, and the authors suggested that the atrial fibrillation may have had a direct effect on left ventricular function despite effective rate control with digoxin and verapamil. The results of this small trial need to be confirmed.
Considering the frequency of atrial fibrillation in the population, the symptomatic impact of the disorder has been little studied. Jenkins et al"2 found quality of life in patients with atrial fibrillation was less than that of patients recovering from myocardial infarction or with severe rheumatoid arthritis, but their patients were about to undergo AV nodal ablation with pacemaker implantation, and were probably drawn from the most symptomatic group. Our own survey and that of others2' demonstrate that exertion dyspnoea, lassitude, and lack of energy are the predominant symptoms of atrial fibrillation. Palpitation, which is commonly perceived to be the principal complaint, features far less in the symptoms that patients spontaneously volunteer. The symptoms of atrial fibrillation are non-specific and often attributed to co-exis-tent disease, but they are very real and often very debilitating. Restoration In addition to the lack of awareness of the adverse effects of atrial fibrillation, the other feature which has encouraged the tacit acceptance of the arrhythmia is the lack of effective therapy. External DC cardioversion can restore sinus rhythm in 70-90% of patients, but atrial fibrillation recurs in the majority within a year. Prophylactic antiarrhythmic drug therapy doubles the number remaining in sinus rhythm,29 30 and still higher figures might be achievable through the use of amiodarone31 or serial drug therapy.32 However, proarrhythmia and an increased risk of sudden death are a concern.'9 34 Further improvements in our ability to restore sinus rhythm have resulted from the development of internal cardioversion (that is, defibrillating with one or both poles within the heart), which has a higher success rate than external cardioversion35 and may be effective in those resistant to external shocks."-"
The duration of atrial fibrillation is one of the best predictors of recurrence following cardioversion, and at least part of the electrophysiological basis for the fact that "atrial fibrillation begets atrial fibrillation" has been demonstrated by Wijffels et 
